Cognition Therapeutics News

Cognition Therapeutics Analyst Ratings

BenzingaAug 12 05:58 ET

HC Wainwright & Co. Maintains Buy on Cognition Therapeutics, Lowers Price Target to $5

BenzingaAug 12 05:57 ET

Cognition Therapeutics Analyst Ratings

BenzingaAug 6 13:22 ET

B.Riley Financial Downgrades Cognition Therapeutics(CGTX.US) to Hold Rating, Cuts Target Price to $1

Moomoo NewsAug 6 07:36 ET

Cognition Therapeutics Analyst Ratings

BenzingaAug 1 06:25 ET

H.C. Wainwright Maintains Cognition Therapeutics(CGTX.US) With Buy Rating, Cuts Target Price to $7

Moomoo NewsJul 31 06:31 ET

Ladenburg Thalmann Maintains Cognition Therapeutics(CGTX.US) With Buy Rating, Cuts Target Price to $5

Moomoo NewsJul 30 12:31 ET

Oppenheimer Maintains Cognition Therapeutics(CGTX.US) With Buy Rating, Maintains Target Price $9

Moomoo NewsJul 30 08:31 ET

Oppenheimer Reaffirms Their Buy Rating on Cognition Therapeutics (CGTX)

TipRanksJul 30 08:06 ET

Cognition Therapeutics Analyst Ratings

BenzingaJul 30 05:52 ET

Cantor Fitzgerald Downgrades Cognition Therapeutics(CGTX.US) to Hold Rating

Moomoo NewsJul 29 16:31 ET

Cognition Therapeutics Analyst Ratings

BenzingaJul 2 13:15 ET

Chardan Research Initiates Cognition Therapeutics With Buy Rating, $11 Price Target

MT NewswiresJun 7 05:12 ET

Cognition Therapeutics Analyst Ratings

BenzingaJun 6 16:34 ET

Cognition Therapeutics Analyst Ratings

BenzingaMay 29 06:57 ET

Buy Rating Affirmed for Cognition Therapeutics on Promising Alzheimer's Drug Candidate CT1812

TipRanksMay 29 06:21 ET

Oppenheimer Sticks to Their Buy Rating for Cognition Therapeutics (CGTX)

TipRanksMay 13 08:10 ET

Analysts Are Bullish on Top Healthcare Stocks: Halozyme (HALO), Cognition Therapeutics (CGTX)

TipRanksApr 16 07:50 ET

Cognition Therapeutics Analyst Ratings

BenzingaMar 28 12:01 ET

Buy Rating Affirmed for Cognition Therapeutics Amid Promising CT1812 Clinical Trials

TipRanksMar 28 07:40 ET